Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.460
-0.030 (-0.86%)
At close: Aug 7, 2025, 4:00 PM
3.700
+0.240 (6.94%)
Pre-market: Aug 8, 2025, 8:40 AM EDT
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $296.10 million as of August 8, 2025. Its market cap has decreased by -8.92% in one year.
Market Cap
296.10M
Enterprise Value
-82.36M
1-Year Change
-8.92%
Ranking
Category
Stock Price
$3.46
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $296.10M, a decrease of -84.72%. That is a compound annual growth rate of -32.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 296.10M | 4.65% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | 3.45B | 78.13% |
| Oct 30, 2020 | 1.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| Novartis AG | 223.01B |
| UnitedHealth Group | 221.95B |
| Novo Nordisk | 213.92B |